A new way to combat Alzheimer’s disease has been discovered by Takaomi Saido and his team at the RIKEN Center for Brain Science (CBS) in Japan.
Risk Adjusted Net Present Value: What is the current valuation of Oncolytics Biotech’s Reolysin
The revenue for Reolysin is expected to reach an annual total of $109 mn by 2038 globally based off GlobalData’s Expiry Model. The drug’s revenue